DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages
Author: Dr Ritva Vyas MBChB, Dermatology Registrar, Waikato Hospital, Hamilton, New Zealand, 2010.
Uraemic pruritus is also called chronic kidney disease associated pruritus (CKD-associated pruritus). Uraemia refers to excessive urea in the blood, and occurs when both kidneys stop working (renal failure). Pruritus (itch) is a common problem for patients with chronic renal failure or end stage renal disease. It affects about one-third of patients on dialysis and is more common with haemodialysis than continuous ambulatory peritoneal dialysis (CAPD).
Uraemic pruritus is not associated with sex, age, ethnicity, duration of dialysis, or cause of renal failure. Pruritus does not arise when uraemia is due to acute renal failure.
Uraemic pruritus is characterised by daily bouts of itching that tend to worsen at night and may prevent sleep. The itch may be generalised or localised to one area, most often the back, abdomen, head and /or arms. In haemodialysis patients, the pruritus is lowest the day after dialysis and peaks 2 days afterwards.
The skin may appear normal or dry (xerosis), with few to numerous scratch marks and/or picked sores.
Uraemic pruritus (renal itch)
Uraemic pruritus can be very unpleasant; about half of affected individuals become agitated or depressed. Uraemic pruritus in haemodialysis patients is associated with a 17% increase in mortality.
Uraemic pruritus is thought to be due to a combination of factors including:
Some patients develop an acquired reactive perforating collagenosis.
The first step in treatment is optimising dialysis efficacy. It is also important to attempt to reduce serum parathyroid hormone to normalise calcium/phosphorus.
Menthol and camphor may be added to an emollient to cool the skin and relieve the itch. Any localised itch may be reduced by frequent applications of topical capsaicin if tolerated.
Other treatments that have been reported to help some individuals include:
In 2019, in a Phase III clinical trial, an agonist of kappa opioid receptors, difelikefalin, was reported to relieve the itch in haemodialysis patients significantly better than placebo.
Kidney transplantation usually results in resolution of uraemic pruritus.
© 2022 DermNet New Zealand Trust.
DermNet NZ does not provide an online consultation service. If you have any concerns with your skin or its treatment, see a dermatologist for advice.